在CKiD研究中,贫血和FGF23之间的关联
Elizabeth Thomas1, Alexandra M Klomhaus2, Marciana L Laster1
1Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Pediatric nephrology (Berlin, Germany)
|September 26, 2023
概括
患有慢性病 (CKD) 的儿童的贫血与较高的纤维细胞生长因子23 (FGF23) 水平有关,但不一定是完整的FGF23. 这表明贫血可能会影响儿科CKD患者的FGF23产生和裂变.
科学领域:
- 儿科脏病学 儿科脏病学
- 内分泌学 在内分泌学.
- 矿物质和骨质新陈代谢
背景情况:
- 纤维细胞生长因子23 (FGF23) 是矿物质和骨疾病的关键激素,特别是在慢性病 (CKD) 中.
- 与CKD相关的贫血和缺铁可能会刺激FGF23的产生,这可能会影响CKD的进展和心血管健康.
- 了解贫血,铁状况和FGF23之间的关系对于管理儿科CKD患者至关重要.
研究的目的:
- 调查贫血和/或铁缺乏症与患有慢性脏病的儿科患者循环FGF23度之间的联系.
- 确定贫血或缺铁是否是儿童慢性病 (CKiD) 队列中FGF23水平升高的独立预测因素.
主要方法:
- 从CKiD研究中对493名儿科患者进行横截面分析.
- 测量包括血红蛋白,铁参数,C端 (总) FGF23和完整的FGF23.
- 使用多变量回归模型来评估关联,并根据相关的共同变量进行调整.
主要成果:
- 贫血儿科CKD患者 (21%) 与非贫血患者相比,总FGF23度显著更高.
- 在调整多个因素后,贫血与增加的FGF23总水平独立相关.
- 缺铁与较高的FGF23总量没有显著关联,贫血与完整的FGF23水平没有关联.
结论:
- 儿科CKD中的贫血与FGF23总量的升高有关,这表明可能对FGF23的产生和裂变产生影响.
- 这些发现强调了贫血和FGF23代谢在患有CKD的儿童之间的复杂相互作用.
- 需要进一步的研究来探索影响FGF23在儿科CKD的非矿物因素.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
16
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
16
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Factors Affecting Erythropoiesis
3.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K


